In this exclusive interview Tobias Noeske, Associate Principal Scientist from AstraZeneca, speaks to Andrea Charles from Pharma IQ, about the recent trends in computational toxicology and critical success factors for transporter studies in drug applications. Noeske also discusses key findings on relationship between BSEP inhibition and molecular physicochemical properties, and why it is important for drugs not to inhibit the bile salt export protein.
Pharmaceuticals & Biotechnology Editor | 06/27/2013
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2024
September 10 - 12, 2024
Düsseldorf, Germany
Register Now |
View Agenda |
Learn More
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More